SCHEMBL3283302

SCHEMBL3283302

N#CSCSc1ccccc1-c1nccs1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.39
ADRA1A P35348 3/20 0.36
ADRA1D P25100 2/20 0.36
ADRA1B P35368 1/20 0.36
RAB9A P51151 1/20 0.36
ADRA2A P08913 1/20 0.33
ADRB2 P07550 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
FBP1 P09467 1/20 0.33
LOXL2 Q9Y4K0 1/20 0.33
CYP2A6 P11509 1/20 0.33
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10448407 0.78 PDPK1 (0.44) PDPK1ADRA1AADRA1DADRA1BRAB9A
SCHEMBL5537083 0.75 PDPK1 (0.52) PDPK1ADRA1AADRA1DADRA1BRAB9A
SCHEMBL5014843 0.72 PDPK1 (0.48) PDPK1ADRA1AADRA1DADRA1BRAB9A
Hydrochloric Acid SCHEMBL9223808 0.71 MAOA (0.47) PDPK1ADRA1AADRA1DADRA1BRAB9A
Hydrochloric Acid SCHEMBL9231141 0.71 MAOA (0.47) PDPK1ADRA1AADRA1DADRA1BRAB9A
SCHEMBL5692672 0.71 PDPK1 (0.64) PDPK1ADRA1AADRA1DADRA1BRAB9A
SCHEMBL8053024 0.70 PDPK1 (0.46) PDPK1ADRA1AADRA1DADRA1BRAB9A
Hydrochloric Acid SCHEMBL9227870 0.69 GABRA1 (0.38) PDPK1ADRA1AADRA1DADRA1BRAB9A
SCHEMBL9232146 0.69 PDPK1 (0.36) PDPK1ADRA1AADRA1DADRA1BRAB9A
SCHEMBL4711790 0.69 PDPK1 (0.48) PDPK1ADRA1AADRA1DADRA1BRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3454656-A1 USE OF A COMPOSITION AND METHOD FOR REDUCING BACTERIAL SPORES IN PULP SUSPENSION Kemira Oyj (FI) 2019-03-20 EP claimed
WO-2017194842-A1 USE OF A COMPOSITION AND METHOD FOR REDUCING BACTERIAL SPORES IN PULP SUSPENSION KEMIRA OYJ (FI) 2017-11-16 WO claimed
EP-0367635-B1 Process for the preparation of 2-thiocyanomethylthiobenzothiazole BUCKMAN LABOR INC (US) 1995-09-20 EP claimed
EP-0367635-A1 Process for the preparation of 2-thiocyanomethylthiobenzothiazole BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1990-05-09 EP claimed
EP-0327206-A1 Method for killing mollusks BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1989-08-09 EP claimed
US-20260028294-A1 NOVEL CROP NUTRITION AND FORTIFICATION COMPOSITION SML LIMITED (IN) 2026-01-29 US disclosed
EP-4203686-B1 PESTICIDAL COMPOSITION COMPRISING ELEMENTAL SULPHUR AND FLUPYRADIFURONE DOSHI HITESHKUMAR ANILKANT (IN) 2026-01-28 EP disclosed
EP-3655519-B1 NOVEL CROP FORTIFICATION, NUTRITION AND CROP PROTECTION COMPOSITION SML LTD (IN) 2025-11-26 EP disclosed
US-12454495-B2 Crop nutrition and fortification composition SML Limitied (IN) 2025-10-28 US disclosed
EP-3820830-B1 AGRICULTURAL COMPOSITION CONTAINING SULPHUR AND METHOD OF OBTENTION THEREOF SML LTD (IN) 2025-09-03 EP disclosed
US-20250134108-A1 NOVEL PESTICIDAL COMPOSITION SML LIMITED (IN) 2025-05-01 US disclosed
US-12246999-B2 Oil dispersion composition SAWANT ARUN VITTHAL (IN) 2025-03-11 US disclosed
CN-1077769-C Synergistic antimicrobial compositions containing 2- (thiocyanomethylthio) benzothiazole and organic acids BUCKMAN LAB INT INC (US) 2002-01-16 CN disclosed
WO-2000004776-A1 PESTICIDAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-02-03 WO disclosed
US-5719172-A CONTROLLING GROWTH OF BACTERIA AND/OR FUNGI BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1998-02-17 US disclosed
EP-0792326-A2 ANTIFOULING PAINT COMPOSITION J.C. HEMPEL'S SKIBSFARVE-FABRIK A/S (DK) 1997-09-03 EP disclosed
CN-1135708-A Synergistic antimicrobial compositions comprising 2-(thiocyanomethylthio) benzothiazole and organic acid BUCKMAN LABOR INC (US) 1996-11-13 CN disclosed
WO-1996015198-A2 ANTIFOULING PAINT COMPOSITION J.C. HEMPEL'S SKIBSFARVE-FABRIK A/S (DK) 1996-05-23 WO disclosed
EP-0367635-A1 Process for the preparation of 2-thiocyanomethylthiobenzothiazole BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1990-05-09 EP disclosed
EP-0327206-A1 Method for killing mollusks BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1989-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028294-A1 NOVEL CROP NUTRITION AND FORTIFICATION COMPOSITION SOD1, SOD3, SLC39A3 PDPK1 2715/4885ADRA1A 4830/4885ADRA1D 4846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.